Metabolic syndrome is a risk associated with the atypical antipsychotic medications. Due to this risk, the nurse expects that what blood work has been ordered? Select all that apply.

Choice A reason: Electrolytes and vitamin D are not primary indicators for metabolic syndrome. While they may be assessed for other reasons, they do not directly monitor the metabolic effects of atypical antipsychotics such as weight gain, insulin resistance, or dyslipidemia. Choice B reason: Fasting glucose is essential for detecting insulin resistance and hyperglycemia, which are key components of metabolic syndrome. Atypical antipsychotics can impair glucose metabolism, increasing the risk for type 2 diabetes. Choice C reason: Lipid profile is critical in assessing dyslipidemia, another hallmark of metabolic syndrome. Atypical antipsychotics can elevate triglycerides and LDL cholesterol while lowering HDL, contributing to cardiovascular risk. Choice D reason: Thyroid stimulating hormone (TSH) evaluates thyroid function but is not directly related to metabolic syndrome. While thyroid dysfunction can affect weight and mood, it is not a standard marker for antipsychotic-induced metabolic changes. Choice E reason: Hemoglobin A1c provides a long-term measure of blood glucose control and is useful in identifying prediabetes or diabetes. It complements fasting glucose and is often ordered to monitor patients on atypical antipsychotics for chronic hyperglycemia.